As Connecticut continues to face one of the world’s deadliest COVID-19 outbreaks, the state’s bioscience industry has aggressively turned its focus to developing new breakthrough vaccines and treatments for the novel coronavirus. Some of the more than 150 vaccine candidates and countless antiviral treatments in production globally are being developed by Connecticut-based or affiliated biopharmaceutical companies … more
Connecticut has long figured as a national leader in the biotech industry. It has only bolstered that standing in the past few months.
A number of companies based in the state have emerged as hubs of research and development for COVID-19 treatment and testing, while work on drugs for other conditions continues to advance … more
Evo Design, a Watertown company, is among eight nationwide chosen by NASA’s Jet Propulsion Laboratory to make its newly designed ventilators for patients ill with coronavirus … more
Researchers in the UConn Department of Biomedical Engineering— a shared department in the schools of Dental Medicine, Medicine, and Engineering—have been working to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including the novel coronavirus (SARS-CoV-2) … more